228 related articles for article (PubMed ID: 37149062)
1. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.
Gerasimenko A; Baldassari S; Baulac S
Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062
[TBL] [Abstract][Full Text] [Related]
2. GATORopathies: The role of amino acid regulatory gene mutations in epilepsy and cortical malformations.
Iffland PH; Carson V; Bordey A; Crino PB
Epilepsia; 2019 Nov; 60(11):2163-2173. PubMed ID: 31625153
[TBL] [Abstract][Full Text] [Related]
3. Epilepsy in the mTORopathies: opportunities for precision medicine.
Moloney PB; Cavalleri GL; Delanty N
Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
[TBL] [Abstract][Full Text] [Related]
4. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
Pirozzi F; Berkseth M; Shear R; Gonzalez L; Timms AE; Sulc J; Pao E; Oyama N; Forzano F; Conti V; Guerrini R; Doherty ES; Saitta SC; Lockwood CM; Pritchard CC; Dobyns WB; Novotny E; Wright JNN; Saneto RP; Friedman S; Hauptman J; Ojemann J; Kapur RP; Mirzaa GM
Brain; 2022 Apr; 145(3):925-938. PubMed ID: 35355055
[TBL] [Abstract][Full Text] [Related]
5. Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia.
Weckhuysen S; Marsan E; Lambrecq V; Marchal C; Morin-Brureau M; An-Gourfinkel I; Baulac M; Fohlen M; Kallay Zetchi C; Seeck M; de la Grange P; Dermaut B; Meurs A; Thomas P; Chassoux F; Leguern E; Picard F; Baulac S
Epilepsia; 2016 Jun; 57(6):994-1003. PubMed ID: 27173016
[TBL] [Abstract][Full Text] [Related]
6. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
[TBL] [Abstract][Full Text] [Related]
7. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
[TBL] [Abstract][Full Text] [Related]
8. mTOR signaling pathway genes in focal epilepsies.
Baulac S
Prog Brain Res; 2016; 226():61-79. PubMed ID: 27323939
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
[TBL] [Abstract][Full Text] [Related]
10. mTOR signaling in epilepsy: insights from malformations of cortical development.
Crino PB
Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
[TBL] [Abstract][Full Text] [Related]
11. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
[TBL] [Abstract][Full Text] [Related]
12. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
[TBL] [Abstract][Full Text] [Related]
13. NPRL3 loss alters neuronal morphology, mTOR localization, cortical lamination and seizure threshold.
Iffland PH; Everett ME; Cobb-Pitstick KM; Bowser LE; Barnes AE; Babus JK; Romanowski AJ; Baybis M; Elziny S; Puffenberger EG; Gonzaga-Jauregui C; Poulopoulos A; Carson VJ; Crino PB
Brain; 2022 Nov; 145(11):3872-3885. PubMed ID: 35136953
[TBL] [Abstract][Full Text] [Related]
14. A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II.
Zhao S; Li Z; Zhang M; Zhang L; Zheng H; Ning J; Wang Y; Wang F; Zhang X; Gan H; Wang Y; Zhang X; Luo H; Bu G; Xu H; Yao Y; Zhang YW
Exp Mol Med; 2019 Jul; 51(7):1-11. PubMed ID: 31337748
[TBL] [Abstract][Full Text] [Related]
15. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.
D'Gama AM; Woodworth MB; Hossain AA; Bizzotto S; Hatem NE; LaCoursiere CM; Najm I; Ying Z; Yang E; Barkovich AJ; Kwiatkowski DJ; Vinters HV; Madsen JR; Mathern GW; Blümcke I; Poduri A; Walsh CA
Cell Rep; 2017 Dec; 21(13):3754-3766. PubMed ID: 29281825
[TBL] [Abstract][Full Text] [Related]
16. Detection of somatic and germline pathogenic variants in adult cohort of drug-resistant focal epilepsies.
Ferri L; Menghi V; Licchetta L; Dimartino P; Minardi R; Davì C; Di Vito L; Cifaldi E; Zenesini C; Gozzo F; Pelliccia V; Mariani V; de Spelorzi YCC; Gustincich S; Seri M; Tassi L; Pippucci T; Bisulli F
Epilepsy Behav; 2024 Apr; 153():109716. PubMed ID: 38508103
[TBL] [Abstract][Full Text] [Related]
17. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
Nguyen LH; Mahadeo T; Bordey A
J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
[TBL] [Abstract][Full Text] [Related]
18. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
[TBL] [Abstract][Full Text] [Related]
19. New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives.
Mühlebner A; Bongaarts A; Sarnat HB; Scholl T; Aronica E
J Anat; 2019 Sep; 235(3):521-542. PubMed ID: 30901081
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
Jeong A; Wong M
J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
